首页> 外文期刊>Research policy >What do patent-based measures tell us about product commercialization? Evidence from the pharmaceutical industry
【24h】

What do patent-based measures tell us about product commercialization? Evidence from the pharmaceutical industry

机译:基于专利的措施可以告诉我们有关产品商业化的信息?制药业的证据

获取原文
获取原文并翻译 | 示例
       

摘要

Patent-based measures are frequently used as indicators in empirical research on innovation and technological change. Currently, there is little evidence as to what extent patent-based indicators relate to product market outcomes. Using a unique dataset that links outcomes from product commercialization in the pharmaceutical industry with detailed patent data, we relate patent-based indicators that capture either an invention's value or the uncertainty surrounding the patenting process to the outcomes of the product development process. Our findings suggest that the speed of commercialization increases with value but reduces with uncertainty. Using a variety of alternative indicators we derive implications for the use and the proper interpretation of individual measures. Moreover, our study has broader implications as it highlights the detrimental effect of uncertainty on the speed of innovation.
机译:在创新和技术变革的实证研究中,基于专利的措施经常被用作指标。当前,关于基于专利的指标在多大程度上与产品市场成果相关的证据很少。我们使用独特的数据集将制药行业产品商业化的成果与详细的专利数据联系起来,从而将基于专利的指标与产品开发过程的成果联系起来,这些指标可捕获发明的价值或专利过程的不确定性。我们的发现表明,商品化的速度随价值而增加,但随着不确定性而降低。通过使用各种替代指标,我们得出了对单个度量的使用和正确解释的含义。而且,我们的研究具有更广泛的意义,因为它突出了不确定性对创新速度的有害影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号